Petrie M. Rainey

powered by
COS Expertise®
University of Washington
School of Medicine
Laboratory Medicine
ProfessorAppointed: 2000
University of Washington
School of Medicine
Laboratory Medicine
Clinical Chemistry
DirectorAppointed: 2001
University of Washington
School of Medicine
Laboratory Medicine
Residency
DirectorAppointed: 2000
Professional Headshot of Petrie M. Rainey

Mailing Address

Laboratory Medicine
P.O. Box 357110
NW 120
Seattle, Washington 98195-7110
United States

Contact Information

Phone: (206) 598-6140
pmrainey@u.washington.edu

Qualifications

M.D., University of North Carolina at Chapel Hill, 1980.
Ph.D., University of California, Berkeley, 1973.
B.S., University of North Carolina at Chapel Hill, 1968.

Expertise and Research Interests

Drugs for the treatment of leishmaniasis: Sodium stibogluconate and meglumine antimonate are the drugs of choice for treating infections with the parasitic protozoan, Leishmania. Despite their use for half a century, little is known of their pharmacology. We are studying the composition, mechanism of action, and pharmacokinetics of these drugs.

AIDS pharmacology: Pharmacokinetics and pharmacodynamics of drugs used to treat HIV infection and associated opportunistic infections. Currently we are studying interactions between drugs for addiction (methadone, LAAM, buprenorphine) and drugs used to treat HIV infection (nucleoside and non-nucleoside reverse transcriptase inhibitors, protease inhibitors).

Laboratory medicine: Analytical and clinical studies of laboratory testing.

Other Expertise

Fellowships, University of Regensburg; University of California (San Francisco)

Keywords

COS Keywords:

AIDS, Genetics, HIV, Human Immunodeficiency Virus, Parasitology, Pharmacokinetics, Pharmacology, Toxicology.

Additional Terms:

Drug Interaction, Leishmania, Mechanism of Action, Therapeutic Drug Monitoring.

Languages

(Reading, Writing, Speaking)

German: (Functional, Functional, Functional)

Memberships

Academy of Clinical Laboratory Physicians and Scientists
Alpha Omega Alpha
American Association for Clinical Chemistry
American College of Medical Toxicology
National Academy of Clinical Biochemistry
Phi Beta Kappa

Honors and Awards

2008, Faculty of the Year, Department of Laboratory Medicine
2003, Faculty of the Year, Department of Laboratory Medicine
1999, Seligson-Golden Award, American Association for Clinical Chemistry

Previous Positions

1999-2000, Professor, Yale University, School of Medicine, Laboratory Medicine
1991-1999, Associate Professor, Yale University, School of Medicine, Laboratory Medicine
1985-1991, Assistant Professor, Yale University, School of Medicine, Laboratory Medicine

Publications

  • Simons SA, Molinelli AR, Sobhani K, Rainey PM, Hoofnagle AN (Mar 2009) Two cases with unusual vancomycin measurements., Clinical chemistry, 55 (3), 578-80; discussion 5 Abstract
  • Baird GS, Rainey PM, Wener M, Chandler W (Mar 2009) Reducing routine ionized calcium measurement., Clinical chemistry, 55 (3), 533-40 Abstract
  • Marney LC, Laha TJ, Baird GS, Rainey PM, Hoofnagle AN (Oct 2008) Isopropanol protein precipitation for the analysis of plasma free metanephrines by liquid chromatography-tandem mass spectrometry., Clinical chemistry, 54 (10), 1729-32 Abstract
  • Roshal M, Turgeon J, Rainey PM (Feb 2008) Rapid quantitative method using spin columns to measure porphobilinogen in urine., Clinical chemistry, 54 (2), 429-31 Abstract
  • McCance-Katz EF, Moody DE, Morse GD, Ma Q, DiFrancesco R, Friedland G, Pade P, Rainey PM (Dec 2007) Interaction between buprenorphine and atazanavir or atazanavir/ritonavir., Drug and alcohol dependence, 91 (2-3), 269-78 Abstract
  • Cruz A, Rainey PM, Herwaldt BL, Stagni G, Palacios R, Trujillo R, Saravia NG (Feb 2007) Pharmacokinetics of antimony in children treated for leishmaniasis with meglumine antimoniate., The Journal of infectious diseases, 195 (4), 602-8 Abstract
  • Rainey PM (Jan 2007) Laboratory turnaround time does not affect emergency department length of stay., American journal of clinical pathology, 127 (1), 154; author reply 15 Abstract
  • McCance-Katz EF, Moody DE, Smith PF, Morse GD, Friedland G, Pade P, Baker J, Alvanzo A, Jatlow P, Rainey PM (Dec 2006) Interactions between buprenorphine and antiretrovirals. II. The protease inhibitors nelfinavir, lopinavir/ritonavir, and ritonavir., Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 43 Suppl 4, S235-46 Abstract
  • McCance-Katz EF, Moody DE, Morse GD, Friedland G, Pade P, Baker J, Alvanzo A, Smith P, Ogundele A, Jatlow P, Rainey PM (Dec 2006) Interactions between buprenorphine and antiretrovirals. I. The nonnucleoside reverse-transcriptase inhibitors efavirenz and delavirdine., Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 43 Suppl 4, S224-34 Abstract
  • Hoofnagle AN, Laha TJ, Rainey PM, Sadrzadeh SM (Dec 2006) Specific detection of anabasine, nicotine, and nicotine metabolites in urine by liquid chromatography-tandem mass spectrometry., American journal of clinical pathology, 126 (6), 880-7 Abstract
  • Rainey PM (Dec 2006) Automatic reporting of estimated glomerular filtration rate--jumping the gun?, Clinical chemistry, 52 (12), 2184-7 Abstract
  • Pierce KM, Hoggard JC, Hope JL, Rainey PM, Hoofnagle AN, Jack RM, Wright BW, Synovec RE (Jul 2006) Fisher ratio method applied to third-order separation data to identify significant chemical components of metabolite extracts., Analytical chemistry, 78 (14), 5068-75 Abstract
  • McCance-Katz EF, Rainey PM, Smith P, Morse GD, Friedland G, Boyarsky B, Gourevitch M, Jatlow P (2006) Drug interactions between opioids and antiretroviral medications: interaction between methadone, LAAM, and delavirdine., The American journal on addictions / American Academy of Psychiatrists in Alcoholism and Addictions, 15 (1), 23-34 Abstract
  • Rainey PM (2006) Laboratory Principles, Goldfrank's Toxicologic Emergencies, 8th Ed., New York, McGraw-Hill, 88-108 pages, ISBN=0071437630 (bookchapter)
  • Perlman DC, Segal Y, Rosenkranz S, Rainey PM, Remmel RP, Salomon N, Hafner R, Peloquin CA, AIDS Clinical Trials Group 309 Team (Dec 2005) The clinical pharmacokinetics of rifampin and ethambutol in HIV-infected, Clinical Infectious Diseases, 41 (11), 1638-47 Abstract
  • McCance-Katz EF, Rainey PM, Smith P, Morse G, Friedland G, Gourevitch M, Jatlow P, Drug interactions between opioids and antiretroviral medications: interaction between methadone, LAAM, and nelfinavir, The American Journal On Addictions, 13(2), 163-80, 2004 Abstract
  • Perlman DC, Segal Y, Rosenkranz S, Rainey PM, Peloquin CA, Remmel RP, Chirgwin K, Salomon N, Hafner R, ACTG 309 Team, The clinical pharmacokinetics of pyrazinamide in HIV-infected persons with tuberculosis, Clinical Infectious Diseases, 38(4), 556-64, February 2004 Abstract
  • Yuan S, Bien C, Wener MH, Simkin P, Rainey PM, Astion ML, Repeat examination of synovial fluid for crystals: is it useful?, Clinical Chemistry, 49(9), 1562-3, September 2003 Abstract
  • McCance-Katz EF, Rainey PM, Friedland G, Jatlow P, The protease inhibitor lopinavir-ritonavir may produce opiate withdrawal in methadone-maintained patients, Clinical Infectious Diseases, 37(4), 476-82, August 2003 Abstract
  • Hori K, Martin TG, Rainey P, Robertson WO, Believe it or not--silver still poisons!, Veterinary and Human Toxicology, 44(5), 291-2, October 2002 Abstract
  • McCance-Katz EF, Gourevitch MN, Arnsten J, Sarlo J, Rainey P, Jatlow P, Modified directly observed therapy (MDOT) for injection drug users with HIV disease, The American Journal On Addictions, 11(4), 271-8, 2002 Abstract
  • Rainey PM, HIV drug interactions: the good, the bad, and the other, Therapeutic Drug Monitoring, 24(1), 26-31, February 2002 Abstract
  • Rainey PM, Friedland GH, Snidow JW, McCance-Katz EF, Mitchell SM, Andrews L, Lane B, Jatlow P, The pharmacokinetics of methadone following co-administration with a lamivudine/zidovudine combination tablet in opiate-dependent subjects, The American Journal On Addictions, 11(1), 66-74, Winter 2002 Abstract
  • McCance-Katz EF, Rainey PM, Friedland G, Kosten TR, Jatlow P, Effect of opioid dependence pharmacotherapies on zidovudine disposition, The American Journal On Addictions, 10(4), 296-307, 2001 Abstract
  • Rigsby MO, Rosen MI, Beauvais JE, Cramer JA, Rainey PM, O'Malley SS, Dieckhaus KD, Rounsaville BJ, Cue-dose training with monetary reinforcement: pilot study of an antiretroviral adherence intervention, Journal of General Internal Medicine, 15(12), 841-7, December 2000 Abstract
  • Rainey PM, Friedland G, McCance-Katz EF, Andrews L, Mitchell SM, Charles C, Jatlow P, Interaction of methadone with didanosine and stavudine, Journal of Acquired Immune Deficiency Syndromes (1999), 24(3), 241-8, July 2000 Abstract
  • Roberts WL, Smith PT, Martin WJ, Rainey PM, Performance characteristics of three serum iron and total iron-binding capacity methods in acute iron overdose, American Journal of Clinical Pathology, 112(5), 657-64, November 1999 Abstract
  • Armstrong LR, Dembry LM, Rainey PM, Russi MB, Khan AS, Fischer SH, Edberg SC, Ksiazek TG, Rollin PE, Peters CJ, Management of a Sabia virus-infected patients in a US hospital, Infection Control and Hospital Epidemiology, 20(3), 176-82, March 1999 Abstract
  • Schumacher C, Brodkin CA, Alexander B, Cullen M, Rainey PM, van Netten C, Faustman E, Checkoway H, Thyroid function in lead smelter workers: absence of subacute or cumulative effects with moderate lead burdens, International Archives of Occupational and Environmental Health, 71(7), 453-8, October 1998 Abstract
  • McCance-Katz E F, Rainey P M, Jatlow P, Friedland G, Methadone effects on zidovudine disposition (AIDS Clinical Trials Group 262), Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 18(5), 435-43, 15 Aug 1998
  • Rainey PM, Outcomes assessment for point-of-care testing [editorial], Clinical Chemistry, 44(8), 1595-6, August 1998
  • Sundar S, Sinha P R, Agrawal N K, Srivastava R, Rainey P M, Berman J D, Murray H W, Singh V P, A cluster of cases of severe cardiotoxicity among kala-azar patients treated with a high-osmolarity lot of sodium antimony gluconate, American Journal of Tropical Medicine and Hygiene, 59(1), 139-43, July 1998
  • Cobb MN, Desai J, Brown LS, Zannikos PN, Rainey PM, The effect of fluconazole on the clinical pharmacokinetics of methadone, Clinical Pharmacology and Therapeutics, 63(6), 655-62, June 1998 Abstract
  • Roberts W L, McMurray W J, Rainey P M, Characterization of the antimonial antileishmanial agent meglumine antimonate (glucantime), Antimicrobial Agents and Chemotherapy, 42(5), 1076-82, May 1998
  • Bates DW, Soldin SJ, Rainey PM, Micelli JN, Strategies for physician education in therapeutic drug monitoring, Clinical Chemistry, 44(2), 401-7, February 1998 Abstract
  • Roberts W L, Hariprashad J, Rainey P M, Murray H W, Pentavalent antimony-mannan conjugate therapy of experimental visceral leishmaniasis, American Journal of Tropical Medicine and Hygiene, 55(4), 444-6, October 1996
  • Rainey P M, Rogers K E, Roberts W L, Metabolite and matrix interference in phenytoin immunoassays, Clinical Chemistry, 42(10), 1645-53, October 1996 Abstract
  • Jacobson J M, Davidian M, Rainey P M, Hafner R, Raasch R H, Luft B J, Pyrimethamine pharmacokinetics in human immunodeficiency virus-positive patients seropositive for Toxoplasma gondii, Antimicrobial Agents and Chemotherapy, 40(6), 1360-5, June 1996
  • Hansson A G, Mitchell S, Jatlow P, Rainey P M, Rapid high-performance liquid chromatographic assay for atovaquone, Journal of chromatography. B, Biomedical Applications, 675(1), 180-2, 12 Jan 1996
  • Roberts W L, Reynolds K M, Heimer R, Jatlow P I, Rainey P M, Pyrimethamine analysis by enzyme inhibition and HPLC assays, American Journal of Clinical Pathology, 104(1), 82-8, July 1995
  • Roberts W L, Berman J D, Rainey P M, In vitro antileishmanial properties of tri- and pentavalent antimonial preparations, Antimicrobial Agents and Chemotherapy, 39(6), 1234-9, June 1995
  • Harrison JH, Rainey PM, Identification of patients for pharmacologic review by computer analysis of clinical laboratory drug concentration data, American Journal of Clinical Pathology, 103(6), 710-7, June 1995 Abstract
  • Schonfeld DJ, Rainey PM, Cullen MR, Showalter DR, Cicchetti DV, Screening for lead poisoning by fingerstick in suburban pediatric practices, Archives of Pediatrics and Adolescent Medicine, 149(4), 447-50, April 1995 Abstract
  • Callahan H L, Roberts W L, Rainey P M, Beverley S M, The PGPA gene of Leishmania major mediates antimony (SbIII) resistance by decreasing influx and not by increasing efflux, Molecular and Biochemical Parasitology, 68(1), 145-9, November 1994
  • Roberts W L, Santos F S, Rainey P M, Malkus H, Holinsky J, Erroneous results with diluted Emit reagents [letter], Clinical Chemistry, 40(8), 1597-8, August 1994 Abstract
  • Schonfeld DJ, Cullen MR, Rainey PM, Berg AT, Brown DR, Hogan JC, Turk DS, Rude CS, Cicchetti DV, Screening for lead poisoning in an urban pediatric clinic using samples obtained by fingerstick, Pediatrics, 94(2 Pt 1), 174-9, August 1994 Abstract
  • Filatov V, Alexandrakis G, Rainey PM, Perazella MA, Gloor P, No detectable systemic absorption of topically administered ophthalmic tobramycin, American Journal of Ophthalmology, 117(3), 402-3, 1994 Abstract
  • Roberts W L, Buckley T J, Rainey P M, Jatlow P I, Solid-phase extraction combined with radioimmunoassay for measurement of zalcitabine (2',3'-dideoxycytidine) in plasma and serum, Clinical Chemistry, 40(2), 211-5, February 1994
  • Rainey P M, Alcohol testing in the clinical laboratory: alternative remedies, Clinical Chemistry, 39(12), 2538-9; discussion 2, December 1993 Abstract
  • Rainey P M, Relation between serum and whole-blood ethanol concentrations, Clinical Chemistry, 39(11 Pt 1), 2288-92, November 1993
  • Roberts W L, Rainey P M, Interference in immunoassay measurements of total and free phenytoin in uremic patients: a reappraisal, Clinical Chemistry, 39(9), 1872-7, September 1993
  • Roberts W L, Rainey P M, Antileishmanial activity of sodium stibogluconate fractions, Antimicrobial Agents and Chemotherapy, 37(9), 1842-6, September 1993
  • Campbell S M, Rainey P M, Leishmania pifanoi: kinetics of messenger RNA expression during amastigote to promastigote transformation in vitro, Experimental Parasitology, 77(1), 1-12, August 1993
  • Roberts W L, Rainey P M, Antimony quantification in Leishmania by electrothermal atomic absorption spectroscopy, Analytical Biochemistry, 211(1), 1-6, 15 May 1993
  • Rainey P M, Roberts W L, Diagnosis and misdiagnosis of poisoning with the cyanide precursor acetonitrile: nail polish remover or nail glue remover?, American Journal of Emergency Medicine, 11(2), 104-8, March 1993 Abstract
  • Leelayoova S, Marbury D, Rainey P M, Mackenzie N E, Hall J E, In vitro tryptophan catabolism by Leishmania donovani donovani promastigotes, Journal of Protozoology, 39(2), 350-8, March 1992
  • Rainey P M, Spithill T W, McMahon-Pratt D, Pan A A, Biochemical and molecular characterization of Leishmania pifanoi amastigotes in continuous axenic culture, Molecular and Biochemical Parasitology, 49(1), 111-8, November 1991
  • Rainey P M, MacKenzie N E, A carbon-13 nuclear magnetic resonance analysis of the products of glucose metabolism in Leishmania pifanoi amastigotes and promastigotes, Molecular and Biochemical Parasitology, 45(2), 307-15, April 1991
  • Lim HM, Price TB, Marsh JC, Rainey PM, Gore JC, Armitage IM, Some factors that influence the plasma lipoprotein 1H NMR spectra of normal and cancer patients: an oncolipid test?, Yale Journal of Biology and Medicine, 64(1), 63-77, 1991 Abstract
  • Rainey PM, Effects of digoxin immune Fab (ovine) on digoxin immunoassays, American Journal of Clinical Pathology, 92(6), 779-86, December 1989 Abstract
  • Rainey P, Santi DV, Formycin B resistance in Leishmania, Biochemical Pharmacology, 33(8), 1374-7, 1984 Abstract
  • Berman JD, Rainey P, Santi DV, Metabolism of formycin B by Leishmania amastigotes in vitro. Comparative metabolism in infected and uninfected human macrophages, Journal of Experimental Medicine, 158(1), 252-7, 1983 Abstract
  • Rainey P, Garrett CE, Santi DV, The metabolism and cytotoxic effects of Formycin B in Trypanosoma cruzi, Biochemical Pharmacology, 32(4), 749-52, 1983 Abstract
  • Rainey P, Santi DV, Metabolism and mechanism of action of formycin B in Leishmania, Proceedings of the National Academy of Sciences (USA), 80(1), 288-92, January 1983 Abstract
  • Rainey P, Hammer-Raber B, Kula MR, Holler E, Modification of L-isoleucyl-tRNA synthetase with L-isoleucyl-bromomethyl ketone. The effect of the catalytic steps, European Journal of Biochemistry, 78(1), 239-49, 1977 Abstract
  • Rainey P, Holler E, Kula MR, Labelling of L-isoleucine tRNA ligase from Escherichia coli with L-isoleucyl-bromomethyl ketone, European Journal of Biochemistry, 63(2), 419-26, 1976 Abstract
  • Rainey P, Bennett EL, Calvin M, Purification of L-isoleucyl t-RNA synthetase by affinity chromatography, Preparative Biochemistry, 4(3), 227-41, 1974 Abstract
  • Holler E, Rainey P, Orme A, Bennett EL, Calvin M, On the active site topography of isoleucyl transfer ribonucleic acid synthetase of Escherichia coli B, Biochemistry, 12(6), 1150-9, 1973 Abstract

Profile Details

Last Updated: 11/4/2009

COS Expertise ID #397131
Reference this profile directly: http://myprofile.cos.com/raineyp31